List of androgens/anabolic steroids available in the United States

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

This is a complete list of androgens/anabolic steroids (AAS) and formulations that are approved by the FDA and available in the United States. AAS like testosterone are used in androgen replacement therapy (ART), a form of hormone replacement therapy (HRT), and for other indications.

Testosterone and esters[edit]

Testosterone (unmodified/non-esterified) is available in the following formulations:

In addition to testosterone itself, the following ester prodrugs of testosterone are available in oil solutions for intramuscular injection:

Testosterone propionate was previously available but was discontinued. A combination of testosterone cypionate and estradiol cypionate (brand name Depo-Testadiol) and a combination of testosterone enanthate and estradiol valerate (brand name Ditate-DS) were also formerly available as oil solutions for intramuscular injection, but these formulations have been discontinued as well.

Oral testosterone undecanoate is not available in the United States.[1][2] Androstanolone (dihydrotestosterone) and esters are not available in the United States.

Synthetic AAS[edit]

Oral, buccal, and/or sublingual[edit]

(Note that while the above AAS remain available in at least one formulation, many of the above-listed brand names have been discontinued.)

Ethylestrenol (Maxibolin) and stanozolol (Winstrol) were previously available but were discontinued.

Intramuscular injection[edit]

Drostanolone propionate (Drolban) and nandrolone phenylpropionate (Durabolin) were previously available but were discontinued.

Weakly androgenic progestins[edit]

The following progestins are weakly androgenic and have been associated with androgenic side effects in women:

Ethisterone (Pranone) was previously available but was discontinued.

Gestrinone and tibolone are also notable androgenic progestins but have never been marketed in the United States.

See also[edit]

Notes[edit]

  1. ^ John E. Morley; Lucretia van den Berg (5 November 1999). Endocrinology of Aging. Springer Science & Business Media. pp. 141–. ISBN 978-1-59259-715-4.
  2. ^ Carrie Bagatell; William J. Bremner (27 May 2003). Androgens in Health and Disease. Springer Science & Business Media. pp. 144–. ISBN 978-1-59259-388-0.

References[edit]